AlloVir (ALVR) Revenue & Revenue Breakdown
AlloVir Revenue Highlights
Main Segment (Y)
Grant
Main Geography (Y)
Grant
AlloVir Revenue by Period
AlloVir Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | -100.00% |
| 2019-12-31 | $165.00K | -85.46% |
| 2018-12-31 | $1.14M | - |
AlloVir generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
AlloVir Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $8.38M | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | -100.00% |
| 2019-03-31 | $165.00K | - |
AlloVir generated - in revenue during Q2 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
AlloVir Revenue Breakdown
AlloVir Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 20 |
|---|---|
| Grant | $900.00K |
AlloVir's latest annual revenue breakdown by segment (product or service), as of Dec 20: Grant (100.00%).
Quarterly Revenue by Product
| Product/Service | Dec 20 | Sep 20 | Jun 20 |
|---|---|---|---|
| Grant | $200.00K | $400.00K | $300.00K |
AlloVir's latest quarterly revenue breakdown by segment (product or service), as of Dec 20: Grant (100.00%).
AlloVir Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 20 |
|---|---|
| Grant | $900.00K |
AlloVir's latest annual revenue breakdown by geography, as of Dec 20: Grant (100.00%).
Quarterly Revenue by Country
| Country | Dec 20 | Sep 20 | Jun 20 |
|---|---|---|---|
| Grant | $200.00K | $400.00K | $300.00K |
AlloVir's latest quarterly revenue breakdown by geography, as of Dec 20: Grant (100.00%).
AlloVir Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| MRUS | Merus | $43.95M | $7.33M |
| AGIO | Agios Pharmaceuticals | $26.82M | $8.62M |
| ADAG | Adagene | $18.11M | $833.34K |
| ANAB | AnaptysBio | $17.16M | $10.97M |
| STOK | Stoke Therapeutics | $8.78M | $4.22M |
| KRON | Kronos Bio | $6.29M | $2.69M |
| CRNX | Crinetics Pharmaceuticals | $4.01M | $640.00K |
| INBX | Inhibrx | $1.80M | - |
| FIXX | Q32 Bio | $1.16M | - |
| BCEL | Atreca | $770.00K | $80.00K |
| LYEL | Lyell Immunopharma | $130.00K | $3.00K |
| ANEB | Anebulo Pharmaceuticals | - | - |
| CGEM | Cullinan Oncology | - | - |
| ALVR | AlloVir | - | - |
| BDTX | Black Diamond Therapeutics | - | - |
| ANTX | AN2 Therapeutics | - | - |
| AVTE | Aerovate Therapeutics | - | - |
| ACRV | Acrivon Therapeutics | - | - |
| MLYS | Mineralys Therapeutics | - | - |
| FDMT | 4D Molecular Therapeutics | - | - |
ALVR Revenue FAQ
What is AlloVir’s yearly revenue?
AlloVir's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. ALVR's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.
What is AlloVir’s quarterly revenue?
AlloVir's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). ALVR's quarterly revenue for Q4 2023 was $8.38M, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022).
What is AlloVir’s revenue growth rate?
AlloVir's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was -100.00%.
What are AlloVir’s revenue streams?
AlloVir's revenue streams in c 20 are Grant
What is AlloVir’s main source of revenue?
For the fiscal year ending Dec 20, the largest source of revenue of AlloVir was Grant. This segment made a revenue of $900K, representing 100.00% of the company's total revenue.